Sichuan Kelun Pharmaceutical Co Ltd (002422) — Capital Reinvestment Ratio
Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Capital Reinvestment Ratio of 0.73x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥537.31 Million) in capital expenditures (CN¥393.58 Million). Check Sichuan Kelun Pharmaceutical Co Ltd (002422) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sichuan Kelun Pharmaceutical Co Ltd Capital Reinvestment Ratio (2007–2025)
This chart tracks Sichuan Kelun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods. For the full cash flow conversion analysis, see 002422 cash flow conversion.
Annual Capital Reinvestment Ratio for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Year-by-year Capital Reinvestment Ratio for Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. See Sichuan Kelun Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.61x | CN¥2.64 Billion | CN¥1.62 Billion | ▲ +64.4% |
| 2024 | 0.37x | CN¥4.49 Billion | CN¥1.68 Billion | ▲ +12.7% |
| 2023 | 0.33x | CN¥5.34 Billion | CN¥1.77 Billion | ▲ +15.7% |
| 2022 | 0.29x | CN¥3.13 Billion | CN¥896.02 Million | ▼ -17.7% |
| 2021 | 0.35x | CN¥2.85 Billion | CN¥990.56 Million | ▼ -37.3% |
| 2020 | 0.55x | CN¥2.22 Billion | CN¥1.23 Billion | ▼ -7.6% |
| 2019 | 0.60x | CN¥2.22 Billion | CN¥1.33 Billion | ▲ +33.4% |
| 2018 | 0.45x | CN¥2.95 Billion | CN¥1.33 Billion | ▼ -63.3% |
| 2017 | 1.23x | CN¥1.20 Billion | CN¥1.48 Billion | ▲ +54.7% |
| 2016 | 0.79x | CN¥1.73 Billion | CN¥1.37 Billion | ▼ -46.5% |
| 2015 | 1.48x | CN¥1.24 Billion | CN¥1.84 Billion | ▼ -34.4% |
| 2014 | 2.26x | CN¥1.22 Billion | CN¥2.76 Billion | ▲ +5.2% |
| 2013 | 2.15x | CN¥1.05 Billion | CN¥2.26 Billion | ▼ -68.8% |
| 2012 | 6.89x | CN¥402.77 Million | CN¥2.77 Billion | ▲ +17.8% |
| 2011 | 5.85x | CN¥342.93 Million | CN¥2.00 Billion | ▲ +34.8% |
| 2010 | 4.34x | CN¥149.29 Million | CN¥647.22 Million | ▲ +294.8% |
| 2009 | 1.10x | CN¥250.69 Million | CN¥275.29 Million | ▲ +7.1% |
| 2008 | 1.02x | CN¥221.08 Million | CN¥226.58 Million | ▼ -1.4% |
| 2007 | 1.04x | CN¥168.42 Million | CN¥175.05 Million | — |